{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:17:30Z","timestamp":1794003450832,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81329003"],"award-info":[{"award-number":["81329003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31430032"],"award-info":[{"award-number":["31430032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671356"],"award-info":[{"award-number":["81671356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Program for Changjiang Scholars and Innovative Research Team in University","award":["IRT_16R37"],"award-info":[{"award-number":["IRT_16R37"]}]},{"name":"the Guangzhou Science and Technology Project","award":["201707020027"],"award-info":[{"award-number":["201707020027"]}]},{"DOI":"10.13039\/501100003453","name":"the Natural Science Foundation of Guangdong","doi-asserted-by":"crossref","award":["2016A030310396"],"award-info":[{"award-number":["2016A030310396"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education","award":["LC2016PY031"],"award-info":[{"award-number":["LC2016PY031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-018-3115-4","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T08:15:20Z","timestamp":1547021720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yiyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-quan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"issue":"9995","key":"3115_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(14)62254-6","volume":"386","author":"R Atun","year":"2015","unstructured":"Atun R. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):721\u20132.","journal-title":"Lancet"},{"issue":"6","key":"3115_CR2","doi-asserted-by":"publisher","first-page":"e65356","DOI":"10.1371\/journal.pone.0065356","volume":"8","author":"L Gu","year":"2013","unstructured":"Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One. 2013;8(6):e65356.","journal-title":"PLoS One"},{"issue":"5","key":"3115_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"J Schildkraut","year":"1965","unstructured":"Schildkraut J. The catecholamine hypothesis of affective disorders a review of supporting evidence. Am J Psychiatry. 1965;122(5):509\u201322.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"3115_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/15622975.2013.804195","volume":"14","author":"M Bauer","year":"2013","unstructured":"Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14(5):334\u201385.","journal-title":"World J Biol Psychiatry"},{"key":"3115_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.7326\/0003-4819-143-6-200509200-00006","volume":"143","author":"RA Hansen","year":"2005","unstructured":"Hansen RA, Gartlehner G, Lohr KN, et al. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med. 2005;143:415\u201326.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3115_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00213-014-3765-1","volume":"232","author":"M Vermeiden","year":"2015","unstructured":"Vermeiden M, Kamperman AM, Vulink ME, et al. Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients. Psychopharmacology. 2015;232(8):1347\u201356.","journal-title":"Psychopharmacology"},{"key":"3115_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.12.001","volume":"152","author":"R Machado-Vieira","year":"2017","unstructured":"Machado-Vieira R, Henter ID, Zarate CA Jr. New targets for rapid antidepressant action. Prog Neurobiol. 2017;152:21\u201337.","journal-title":"Prog Neurobiol"},{"key":"3115_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","volume":"156","author":"M Naughton","year":"2014","unstructured":"Naughton M, Clarke G, O\u2019Leary OF, et al. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J Affect Disord. 2014;156:24\u201335.","journal-title":"J Affect Disord"},{"key":"3115_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0165-0327(97)00063-3","volume":"45","author":"G Winokur","year":"1997","unstructured":"Winokur G. All roads lead to depression: clinically homogeneous, etiologically heterogeneous. J Affect Disord. 1997;45:97\u2013108.","journal-title":"J Affect Disord"},{"issue":"7","key":"3115_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/omi.2014.0164","volume":"19","author":"WH Shao","year":"2015","unstructured":"Shao WH, Chen JJ, Fan SH, et al. Combined metabolomics and proteomics analysis of major depression in an animal model: perturbed energy metabolism in the chronic mild stressed rat cerebellum. OMICS. 2015;19(7):383\u201392.","journal-title":"OMICS"},{"issue":"4","key":"3115_CR11","doi-asserted-by":"publisher","first-page":"e0176725","DOI":"10.1371\/journal.pone.0176725","volume":"12","author":"YY Liu","year":"2017","unstructured":"Liu YY, Zhou XY, Yang LN, et al. Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats. PLoS One. 2017;12(4):e0176725.","journal-title":"PLoS One"},{"issue":"1","key":"3115_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00406-016-0709-2","volume":"267","author":"VM Saia-Cereda","year":"2017","unstructured":"Saia-Cereda VM, Cassoli JS, Martins-de-Souza D, et al. Psychiatric disorders biochemical pathways unraveled by human brain proteomics. Eur Arch Psychiatry Clin Neurosci. 2017;267(1):3\u201317.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3115_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0447.2000.101001011.x","volume":"101","author":"P Videbech","year":"2000","unstructured":"Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 2000;101:11\u201320.","journal-title":"Acta Psychiatr Scand"},{"key":"3115_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0006-3223(96)00097-2","volume":"41","author":"M Buchsbaum","year":"1997","unstructured":"Buchsbaum M, Wu J, Siegel B, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997;41:15\u201322.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"3115_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1515\/revneuro-2016-0087","volume":"28","author":"F Salehpour","year":"2017","unstructured":"Salehpour F, Rasta SH. The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder. Rev Neurosci. 2017;28(4):441\u201353.","journal-title":"Rev Neurosci"},{"issue":"4","key":"3115_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/archpsyc.1997.01830160092012","volume":"54","author":"JD Bremner","year":"1997","unstructured":"Bremner JD. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry. 1997;54(4):364.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"3115_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1460-9568.2010.07345.x","volume":"32","author":"AF MacAskill","year":"2010","unstructured":"MacAskill AF, Atkin TA, Kittler JT. Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci. 2010;32(2):231\u201340.","journal-title":"Eur J Neurosci"},{"key":"3115_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbr.2016.03.005","volume":"305","author":"L Liu","year":"2016","unstructured":"Liu L, Zhou X, Zhang Y, et al. The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression. Behav Brain Res. 2016;305:148\u201356.","journal-title":"Behav Brain Res"},{"issue":"1","key":"3115_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63\u201377.","journal-title":"Neuropharmacology"},{"issue":"5","key":"3115_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","volume":"15","author":"N Price","year":"2012","unstructured":"Price N, Gomes A, Ling A, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15(5):675\u201390.","journal-title":"Cell Metab"},{"issue":"7562","key":"3115_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nature14659","volume":"523","author":"Consortium C","year":"2015","unstructured":"Consortium C. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 2015;523(7562):588\u201391.","journal-title":"Nature"},{"issue":"4","key":"3115_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"AC Andreazza","year":"2010","unstructured":"Andreazza AC, Shao L, W JF, et al. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"3115_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.pnpbp.2010.07.030","volume":"35","author":"A Gardner","year":"2011","unstructured":"Gardner A, Boles RG. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):730\u201343.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3115_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pbb.2012.12.027","volume":"104","author":"S Aboul-Fotouh","year":"2013","unstructured":"Aboul-Fotouh S. Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative:nitrosative DNA damage in chronically stressed rats. Pharmacol Biochem Behav. 2013;104:105\u201312.","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"3115_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/JCP.0000000000000326","volume":"35","author":"B Forester","year":"2015","unstructured":"Forester B, Harper D, Georgakas J, et al. Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression. J Clin Psychopharmacol. 2015;35(3):338\u201340.","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u20133","key":"3115_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jad.2011.07.010","volume":"135","author":"DG Kondo","year":"2011","unstructured":"Kondo DG, Sung YH, Hellem TL, et al. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. J Affect Disord. 2011;135(1\u20133):354\u201361.","journal-title":"J Affect Disord"},{"key":"3115_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj2810021","volume":"281","author":"T Wallimann","year":"1992","unstructured":"Wallimann T, Wyss M, Brdiczka D, et al. Intracellular compartmentation, structure and function of creatine kinaseisoenzymesin tissueswithhighandfluctuatingenergy demands: the \u201cphosphocreatine circuit\u201d for cellular energy homeostasis. Biochem J. 1992;281:21\u201340.","journal-title":"Biochem J"},{"issue":"6","key":"3115_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nm.3162","volume":"19","author":"X Cao","year":"2013","unstructured":"Cao X, Li LP, Wang Q, et al. Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med. 2013;19(6):773\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"3115_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s002280050719","volume":"56","author":"H Agteresch","year":"2000","unstructured":"Agteresch H, Dagnelie P, Rietveld T, et al. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol. 2000;56(1):49\u201355.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3115_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/jhep.2002.31318","volume":"35","author":"S Leij-Halfwerk","year":"2002","unstructured":"Leij-Halfwerk S, Agteresch HJ, Sijens PE, et al. Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study. Hepatology. 2002;35(2):421\u20134.","journal-title":"Hepatology"},{"issue":"2","key":"3115_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12325-011-0091-4","volume":"29","author":"E Strumia","year":"2012","unstructured":"Strumia E, Pelliccia F, D'Ambrosio G. Creatine phosphate: pharmacological and clinical perspectives. Adv Ther. 2012;29(2):99\u2013123.","journal-title":"Adv Ther"},{"issue":"9","key":"3115_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1176\/appi.ajp.2012.12010009","volume":"169","author":"IK Lyoo","year":"2012","unstructured":"Lyoo IK, Yoon S, Kim TS, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. Am J Psychiatry. 2012;169(9):937\u201345.","journal-title":"Am J Psychiatry"},{"issue":"3\u20134","key":"3115_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/15504263.2015.1100471","volume":"11","author":"TL Hellem","year":"2015","unstructured":"Hellem TL, Sung YH, Shi XF, et al. A pilot study of creatine as a novel treatment for depression in methamphetamine using females. J Dual Diagn. 2015;11(3\u20134):189\u2013202.","journal-title":"J Dual Diagn"},{"issue":"6","key":"3115_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.biopsych.2015.11.027","volume":"80","author":"S Yoon","year":"2016","unstructured":"Yoon S, Kim JE, Hwang J, et al. Effects of creatine monohydrate augmentation on brain metabolic and network outcome measures in women with major depressive disorder. Biol Psychiatry. 2016;80(6):439\u201347.","journal-title":"Biol Psychiatry"},{"key":"3115_CR35","unstructured":"ALERT O. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. 2005."},{"issue":"2","key":"3115_CR36","first-page":"132","volume":"29","author":"M-Z Yang","year":"2016","unstructured":"Yang M-Z, Zhou Y-M, Wu Y-F, Ge X-Y, Wu Q-L. Clinical observation of electroacupuncture for depression and its brain response monitored by fMRI. Sichuan Mental Health. 2016;29(2):132\u20136.","journal-title":"Sichuan Mental Health"},{"key":"3115_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-6215-14-2","volume":"14","author":"Y-F Chen","year":"2013","unstructured":"Chen Y-F, Liu J-H, Xu N-G, et al. Effects of acupuncture treatment on depression insomnia: a study protocol of a multicenter randomized controlled trial. Trials. 2013;14:2.","journal-title":"Trials"},{"key":"3115_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","volume":"23","author":"JB Williams","year":"2008","unstructured":"Williams JB, Kobak KA, Bech P, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. 2008;23:120\u20139.","journal-title":"Int Clin Psychopharmacol"},{"key":"3115_CR39","first-page":"225","volume-title":"Scale manual of behavior medicine","author":"Association. CM","year":"2005","unstructured":"Association. CM. Scale manual of behavior medicine. Beijing: Chinese Medical Electronic Audio and Video Publishing House; 2005. p. 225\u20136, 485-9."},{"issue":"7","key":"3115_CR40","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The Clinical Global Impressions Scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"3115_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3928\/0048-5713-20020901-06","volume":"32","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:1\u20137.","journal-title":"Psychiatr Ann"},{"key":"3115_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/bmj.4.5726.18","volume":"4","author":"M Asberg","year":"1970","unstructured":"Asberg M, Cronholm B, Sjoqvist F, et al. Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J. 1970;4:18\u201321.","journal-title":"Br Med J"},{"issue":"4","key":"3115_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287\u201391.","journal-title":"Pharm Stat"},{"key":"3115_CR44","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects[J]. Jama. 2013;310(20):2191.","DOI":"10.1001\/jama.2013.281053"},{"key":"3115_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1176\/ajp.154.1.116","volume":"154","author":"CM Moore","year":"1997","unstructured":"Moore CM, Christensen JD, Lafer B, et al. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosporous-31 magnetic resonance spectroscopy study. Am J Psychiatry. 1997;154:116\u20138.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"3115_CR46","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.biopsych.2007.11.020","volume":"63","author":"DV Iosifescu","year":"2008","unstructured":"Iosifescu DV, Bolo NR, Nierenberg AA, et al. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry. 2008;63(12):1127\u201334.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"3115_CR47","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/gps.2230","volume":"24","author":"BP Forester","year":"2009","unstructured":"Forester BP, Harper DG, Jensen JE, et al. 31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression. Int J Geriatr Psychiatry. 2009;24(8):788\u201397.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"3115_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00127-005-0865-6","volume":"40","author":"MT Compton","year":"2005","unstructured":"Compton MT, Thompson NJ, Kaslow NJ. Social environment factors associated with suicide attempt among low-income African Americans: the protective role of family relationships and social support. Soc Psychiatry Psychiatr Epidemiol. 2005;40(3):175\u201385.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3115_CR49","doi-asserted-by":"crossref","unstructured":"Zeeck A, Von Wietersheim J, Weiss H, et al. The INDDEP study: inpatient and day hospital treatment for depression\u2014symptom course and predictors of change. BMC Psychiatry. 2013;13(1):100.","DOI":"10.1186\/1471-244X-13-100"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3115-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T19:12:40Z","timestamp":1578510760000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3115-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3115-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"28 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical Ethics Committee of Zhujiang Hospital, Southern Medical University, China (2017-SJNK-001).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations (Addtional file ).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}